Filtered By:
Source: International Journal of Cardiology

This page shows you your search results in order of relevance. This is page number 4.

Order by Relevance | Date

Total 880 results found since Jan 2013.

Validation of algorithms to identify stroke risk factors in patients with acute ischemic stroke, transient ischemic attack, or intracerebral hemorrhage in an administrative claims database
Stroke patients have a high risk for recurrence, which is positively correlated with the number of risk factors. The assessment of risk factors is essential in both stroke outcomes research and the surveillance of stroke burden. However, methods for assessment of risk factors using claims data are not well developed.
Source: International Journal of Cardiology - April 13, 2016 Category: Cardiology Authors: Sheng-Feng Sung, Cheng-Yang Hsieh, Huey-Juan Lin, Yu-Wei Chen, Yea-Huei Kao Yang, Chung-Yi Li Source Type: research

Sleep duration and risk of stroke events and stroke mortality: A systematic review and meta-analysis of prospective cohort studies
Numerous studies have suggested the relationship between sleep duration and risks of stroke mortality and morbidity, however, the effect estimates varied substantially across studies and it remains unknown how many hours of habitual sleep are associated with the lowest risk of stroke outcomes. Therefore, we performed a dose –response meta-analysis of prospective cohort studies to evaluate the relation of sleep duration with risk of total mortality and stroke events.
Source: International Journal of Cardiology - August 23, 2016 Category: Cardiology Authors: Wenzhen Li, Dongming Wang, Shiyi Cao, Xiaoxv Yin, Yanhong Gong, Yong Gan, Yanfeng Zhou, Zuxun Lu Source Type: research

Characteristics and outcomes of ischemic stroke in patients with known atrial fibrillation or atrial fibrillation diagnosed after stroke
It is unclear whether ischemic stroke patients with known atrial fibrillation (KAF) had different outcomes than those with atrial fibrillation diagnosed after stroke (AFDAS). We aimed to explore the characteristics and outcomes in ischemic stroke patients with KAF or AFDAS.
Source: International Journal of Cardiology - April 13, 2018 Category: Cardiology Authors: Cheng-Yang Hsieh, Cheng-Han Lee, Darren Philbert Wu, Sheng-Feng Sung Source Type: research

The real world of stroke incidence in patients with hypertrophic cardiomyopathy
We have read a paper with great interest written by Fumagalli and colleagues concerning “the incidence of stroke in patients with hypertrophic cardiomyopathy (HCM) among different heart rhythm” [1]. In this paper, the authors found that stroke rates in HCM patients no prior history of atrial fibrillation (AF), stroke rates were similar in those with de novo AF or stable sinus rate (SR). And they further observed that severe left atrium dilatation was a powerful risk factor, irrespective of AF. The results provided evidence for the anticoagulation strategies to prevent stroke in patients with HCM.
Source: International Journal of Cardiology - July 7, 2023 Category: Cardiology Authors: Xinru Chen Tags: Letter to the Editor Source Type: research

Ivabradine is BEAUTIFUL in concurrent acute coronary syndrome and stroke
We report the safe use of oral ivabradine in 2 patients with concurrent ACS and stroke, achieving heart rate reduction and angina relief without affecting blood pressure.
Source: International Journal of Cardiology - September 20, 2012 Category: Cardiology Authors: Pow-Li Chia, David Foo Tags: Online letters to the Editor Source Type: research

Shared and non-shared familial susceptibility of coronary heart disease, ischemic stroke, peripheral artery disease and aortic disease
Abstract: Background: Little is known about whether the four main manifestations of arterial vascular disease (coronary heart disease=CHD, ischemic stroke, peripheral artery disease=PAD, and aortic (i.e. atherosclerosis/aneurysm) disease=AD) share familial susceptibility. The aim of this nationwide study was to determine the familial risks of concordant (same disease in proband and exposed relative) and discordant (different disease in proband and exposed relative) cardiovascular disease (CVD).Methods: Data from the Swedish Multigeneration Register on individuals aged 0–76years were linked to Swedish Hospital Discharge R...
Source: International Journal of Cardiology - May 3, 2013 Category: Cardiology Authors: Susanna Calling, Jianguang Ji, Jan Sundquist, Kristina Sundquist, Bengt Zöller Tags: Original Articles Source Type: research

The “know your numbers” program in Atahualpa — A pilot study aimed to reduce cardiovascular diseases and stroke burden in rural communities of developing countries
The burden of cardiovascular diseases and stroke is steadily increasing in many low- and middle-income countries, to the point that these conditions have been considered as the new epidemics of the developing world . The World Health Organization has set a global goal of reducing deaths from non-communicable diseases (including stroke and ischemic heart disease) by 25% by 2025 . It seems that people living in rural communities are most vulnerable to these “new epidemics”. There, a process of epidemiologic transition is aggravated by poor access to medical care and by income issues that preclude people to afford the cos...
Source: International Journal of Cardiology - May 6, 2013 Category: Cardiology Authors: Oscar H. Del Brutto, Martha Montalván, Daniel Tettamanti, Ernesto Peñaherrera, Rocío Santibáñez, Freddy Pow-Chon-Long, Victor J. Del Brutto Tags: Letters to the Editor Source Type: research

Low stroke risk after elective cardioversion of atrial fibrillation: An analysis of the Flec-SL trial
Conclusion: Strokes are rare in this large, prospectively followed cohort of patients undergoing cardioversion for AF and receiving antithrombotic therapy following local routine. These results support adherence to current recommendations for anticoagulation during cardioversion of AF.
Source: International Journal of Cardiology - July 22, 2013 Category: Cardiology Authors: Stavros Apostolakis, Karl Georg Haeusler, Michael Oeff, Andras Treszl, Dietrich Andresen, Martin Borggrefe, Gregory Y.H. Lip, Thomas Meinertz, Ulrich Parade, Alexander Samol, Gerhard Steinbeck, Karl Wegscheider, Günter Breithardt, Paulus Kirchhof Tags: Original Articles Source Type: research

Al-Akhawayni's views on stroke
From the dawn of medicine physicians were familiar with the manifestations caused by a cerebrovascular accident (stroke) . Throughout the centuries, the continued practices of the scholars, their observations, experimentation, and theories on various medical subjects such as strokes, resulted in today's knowledge on them. Muslim scientists were among the first to play a role in this progressive path . Stroke was among those which they investigated and contributed to its concept . In this respect, we present the views of the medieval physician, Al-Akhawayni Bukhari (?–983AD), concerning the issues of a stroke.
Source: International Journal of Cardiology - January 31, 2014 Category: Cardiology Authors: Hassan Yarmohammadi, Behnam Dalfardi Tags: Letters to the Editor Source Type: research

Differential association of chronic obstructive pulmonary disease with myocardial infarction and ischemic stroke in a nation-wide cohort
Chronic obstructive pulmonary disease (COPD) has been associated with an increased risk of cardiovascular disease, which has been suggested to relate to both similar risk factors and to similar pathophysiological mechanisms . The latter notion has also received support from pharmacoepidemiological studies, suggesting reduced cardiovascular risk by respiratory medications . However, the full impact of COPD on myocardial infarction (MI) and stroke in a population-based cohort remains to be fully investigated. The aim of the present study was to outline the association of COPD with MI and stroke. To this end, we analyzed the ...
Source: International Journal of Cardiology - April 7, 2014 Category: Cardiology Authors: Li Yin, Catarina Lensmar, Erik Ingelsson, Magnus Bäck Tags: Letters to the Editor Source Type: research

Non-Vitamin K Oral Anticoagulants (NOACs) for stroke prevention in Asian patients with atrial fibrillation: Time for a reappraisal
Non-Vitamin K Antagonist Oral Anticoagulants (NOACs) have changed the landscape for stroke prevention in atrial fibrillation (AF). Given the huge burden of AF in Asians, more attention to stroke prevention is clearly needed. Aiming to provide an overview and reappraisal of stroke prevention in Asians with AF, we searched MEDLINE for information on NOACs in Asians. In addition, abstracts from national and international cardiovascular meetings were studied to identify unpublished studies.In the 4 recent Phase 3 trials comparing NOACs to warfarin, a consistent pattern is evident.
Source: International Journal of Cardiology - November 26, 2014 Category: Cardiology Authors: Gregory Y.H. Lip, Kang-Ling Wang, Chern-En Chiang Tags: Review Source Type: research

Non-vitamin K antagonist oral anticoagulants (NOACs) for stroke prevention in Asian patients with atrial fibrillation: Time for a reappraisal
Non-vitamin K antagonist oral anticoagulants (NOACs) have changed the landscape for stroke prevention in atrial fibrillation (AF). Given the huge burden of AF in Asians, more attention to stroke prevention is clearly needed. Aiming to provide an overview and reappraisal of stroke prevention in Asians with AF, we searched MEDLINE for information on NOACs in Asians. In addition, abstracts from national and international cardiovascular meetings were studied to identify unpublished studies.In the 4 recent Phase 3 trials comparing NOACs to warfarin, a consistent pattern is evident.
Source: International Journal of Cardiology - November 26, 2014 Category: Cardiology Authors: Gregory Y.H. Lip, Kang-Ling Wang, Chern-En Chiang Tags: Review Source Type: research

Myocardial fibrosis in stroke survivors
Stroke survivors are most likely to die of cardiac death, yet few undergo comprehensive cardiac assessment to look for reversible causes. Myocardial fibrosis (MF) is not only the hallmark of cardiomyopathy, but also a substrate for sudden cardiac death, ventricular tachyarrhythmia and heart failure. Procollagen carboxyl-terminal telopeptide (PICP) was found to be a marker of MF. The relationship between PICP and cardiac abnormalities in stroke survivors is unknown. We recently showed that MF in stroke survivors can be treated by spironolactone and amiloride in a randomised placebo-controlled cross-over study with reduction...
Source: International Journal of Cardiology - March 19, 2015 Category: Cardiology Authors: K. Wong, S. Sze, S. Wong, S. McSwiggan, V. Allgar, R. MacWalter, A.D. Struthers Tags: Letter to editor Source Type: research

Antithrombotic treatment for stroke prevention in atrial fibrillation: The Asian agenda
Atrial fibrillation (AF) is the most common heart arrhythmia. Untreated AF incurs a considerable burden of stroke and associated healthcare costs. Asians have AF risk factors similar to Caucasians and similarly increased risk of AF-related stroke; however, with a vast and rapidly aging population, Asia bears a disproportionately large disease burden. Urgent action is warranted to avert this potential health crisis. Antithrombotic therapy with oral anticoagulants is the most effective means of preventing stroke in AF and is a particular priority in Asia given the increasing disease burden.
Source: International Journal of Cardiology - March 26, 2015 Category: Cardiology Authors: Chen-Huan Chen, Mien-Cheng Chen, Harry Gibbs, Sun U. Kwon, Sidney Lo, Young Keun On, Azhari Rosman, Nijasri C. Suwanwela, Ru San Tan, Louie S. Tirador, Andreas Zirlik Tags: Review Source Type: research